Gynecol Endocrinol 34:704708
[Crossref] Colombino M, Paliogiannis P, Cossu A, De Re V, Miolo G, et al
Patients with a BMI of 30 kg/m or greater who are considering GLP-1 therapy should schedule a visit with a board-certified endocrinologist or obesity medicine specialist, request baseline metabolic labs (HbA1c, fasting lipids, hepatic function panel), and discuss a 12-month treatment plan that includes dietary modification and physical activity alongside pharmacotherapy 7
During low intensity, carnitine supplementation indeed increases fat oxidation and thereby spared muscle glycogen (stored carbohydrates)
Liraglutide showed similar benefits in the LEADER trial
These evidence-based approaches address the fundamental physiological mechanisms that influence appetite, metabolism, and weight regulation, providing a more reliable path to sustainable health improvements than unproven patches.